Avaliação da Coerência Cardíaca Associada à Hipnose Médica na Ansiedade Pré-Operatória em Cirurgia Oncológica (COHEC2)
Estudo Fase III Avaliando um Programa de Intervenção Não Medicamentosa (NDI) por Respiração Guiada por Frequência Fixa (Coerência Cardíaca) Associada à Hipnose Médica na Ansiedade Pré-Operatória em Cirurgia Oncológica
The investigator proposes to use the cardiac coherence technique (Cardiac Coherence) coupled with a hypnosis session to reduce pre-operative anxiety.
Visão geral do estudo
Status
Status
Condições
Condições
Intervenção / Tratamento
Intervenção / Tratamento
Descrição detalhada
The perioperative period is recognized as anxiety-provoking for most patients. In oncology, 60 to 80% of patients suffer from stress throughout their treatment. If for some patients, this anxiety is more or less manageable, for others, it is the major concern with regard to their intervention.
For many years, pharmacological premedication, especially with benzodiazepines, has been the gold standard for the treatment of preoperative anxiety, but this systematic prescription is increasingly controversial, especially in populations most exposed to side effects, such as elderly subjects and patients with cardiac or respiratory pathologies.
The aim of this study is to propose an alternative to pharmacological premedication by a non-drug approach.
The two techniques (the Fixed Rate Guided Breathing Technique = cardiac coherence and hypnosis) can potentiate each other and become synergistic. Thus, for patients undergoing oncological surgery, regular practice of cardiac coherence coupled with hypnosis prior to their surgery should enable them to better manage perioperative anxiety and thus significantly reduce their level of anxiety on the day of their surgery.
The association of the 2 techniques combines several advantages:
- It is totally "physiological", free and immediately available for the patient and without any undesirable effect;
- It gives autonomy to the patient to manage his stress, making him independent of chemical molecules, the presence of a third party or expensive equipment.
- It will allow oncology patients to use it throughout their care (invasive examinations, MRI imaging, heavy and complex care such as certain dressings, etc.)
This work will allow:
- To give oncology patients the possibility to be actors of their care by a self-management of their anxiety in substitution or complement of a medicated approach;
- To map anxiety in oncology surgery using a simple scale such as the EVA, which has not yet been done;
- To identify the most anxious patients in order to provide them with the appropriate management (pharmacological and/or NMI) before their surgery;
- To evaluate the correlation between the level of preoperative anxiety and the occurrence of postoperative adverse events;
- To evaluate the correlation between the level of anxiety and the quality of recovery (QoR) and the postoperative experience (EVAN-G).
Patients in the experimental group will be interviewed to explain how to perform the cardiac coherence and hypnosis sessions at home before the surgery.
Tipo de estudo
Tipo de estudo
Inscrição (Real)
Inscrição
Estágio
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Lyon, França
- Centre Léon Bérard
-
Toulouse, França
- Institut Universitaire du Cancer Toulouse - Oncopole
-
Villejuif, França
- Institut Gustave Roussy
-
-
Hérault
-
Montpellier, Hérault, França, 34298
- Institut régional du cancer de Montpellier
-
-
Critérios de participação
Critérios de elegibilidade
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Age ≥ 18 years old
- Patient with a scheduled surgery for a cancer (suspected or declared) with a classic or ambulatory hospitalization
- Patients requiring general anesthesia with or without associated loco-regional anesthesia or loco-regional anesthesia alone
- Patient with a smartphone or a tablet or a computer and able to install the application
- Inclusion of the patient minimum 7 days before the date of the surgery
- Patient who signed the informed consent
- Patient affiliated to a French social security system
Exclusion Criteria:
- Emergency surgery
- Plastic surgery for reconstruction: lipomodelling
- Prophylactic surgery: no suspected or existing cancer
- Bradycardia (< 50 beats/minute) with β-blockers
- Severe heart failure with ventricular ejection fraction < 40%
- Uncontrolled chronic pain for more than three months on morphine
- Patient with unstable epilepsy or respiratory pathology with rest dyspnea
- Patient used to and having a regular and habitual practice of relaxation techniques such as yoga, hypnosis, sophrology, meditation, music therapy, virtual reality, ...
- Medical (neurological, psychiatric, etc.) or psychological conditions not allow for participation in the protocol (completion of questionnaires and booklet, compliance with the cardiac coherence program coupled with hypnosis)
- Deaf patient without hearing aids
- Patient under guardianship or curatorship
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Número de braços
Armas e Intervenções
Grupo de Participantes / BraçoGrupo de Participantes / Braço |
Intervenção / TratamentoIntervenção / Tratamento |
|---|---|
|
Experimental: Experimental group
Classic management of the preoperative period with a cardiac coherence program coupled with hypnosis. |
At home the patient will perform the cardiac coherence sessions between 7 days and a maximum of 15 days before the surgery through the application "Respirelax": 3 sessions per day, lasting 5 minutes with a breathing frequency of 6 cycles/min for a period of 7 days minimum and maximum 15 days. An audio tape read in a hypnotic tone can be listened to by the patient during the cardiac coherence program or at another time of the day (see the text of the audio tape). |
|
Sem intervenção: Control group
Classic management of the preoperative period |
O que o estudo está medindo?
Medidas de resultados primários
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Visual Analogue Scale (VAS) of global anxiety
Prazo: The morning of the surgery (Day 0) upon arrival in the operating room
|
Visual Analogue Scale (VAS) of global anxiety is a anxiety self-assessment scale that allows the patient to self-assess his or her anxiety using a cursor. The scale ranges from 0 (no anxiety) to 100 (maximum anxiety). |
The morning of the surgery (Day 0) upon arrival in the operating room
|
Medidas de resultados secundários
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Program compliance
Prazo: Between -15 to -7 days before surgery (Day -15 to Day -7) until the day of surgery (Day 0)
|
Program compliance rate of patients in the experimental group. A patient is considered compliant if he declares to have completed at least 2/3 of the proposed Cardiac Coherence sessions + listening to hypnotic tape (at least 5 days /7). |
Between -15 to -7 days before surgery (Day -15 to Day -7) until the day of surgery (Day 0)
|
|
Measurement of global and specific anxiety level by using a Visual Analogue Scale (VAS)
Prazo: Between -15 to -7 days before surgery (Day -15 to Day -7)
|
Visual Analogue Scale (VAS) of anxiety is a anxiety self-assessment scale that allows the patient to self-assess his or her anxiety using a cursor. The scale ranges from 0 (no anxiety) to 100 (maximum anxiety). The patient assesses his global and specific anxiety related to: surgery, anesthesia, COVID infectious risk, fear of the unknown, oncological disease |
Between -15 to -7 days before surgery (Day -15 to Day -7)
|
|
Measurement of global anxiety level by using a Visual Analogue Scale (VAS)
Prazo: Between -15 to -7 days before surgery and the day of surgery (Day 0)
|
Visual Analogue Scale (VAS) of global anxiety is a anxiety self-assessment scale that allows the patient to self-assess his or her anxiety using a cursor. The scale ranges from 0 (no anxiety) to 100 (maximum anxiety). |
Between -15 to -7 days before surgery and the day of surgery (Day 0)
|
|
The preoperative anxiety score by using the Amsterdam Preoperative Anxiety and Information Scale (APAIS)
Prazo: Between -15 to -7 days before surgery
|
The Amsterdam Preoperative Anxiety and Information Scale (APAIS) is a self-report questionnaire comprising six questions that have been developed and validated to evaluate the preoperative anxiety of patients. This global index assesses three separate areas: anxiety about anaesthesia, anxiety about surgery, and the desire for information. The scale scores six items from 1 to 5 (1 = absence, 5 = extreme). The APAIS scale will be used to determine the psychological profile of patients between "blunting" and "monitoring" types |
Between -15 to -7 days before surgery
|
|
VAS values and individual psycho-clinical characteristics
Prazo: Between -15 to -7 days before surgery and the day of surgery (Day 0)
|
Visual Analogue Scale (VAS) of global anxiety is a anxiety self-assessment scale that allows the patient to self-assess his or her anxiety using a cursor. The scale ranges from 0 (no anxiety) to 100 (maximum anxiety) (defined as VAS at Day 0 ≥ 40), and individual psycho-clinical characteristics (gender, smoking, psychological questionnaires). |
Between -15 to -7 days before surgery and the day of surgery (Day 0)
|
|
Number of patients taking benzodiazepine
Prazo: The day after surgery (Day 1)
|
Rate of patients taking benzodiazepines in the 2 groups |
The day after surgery (Day 1)
|
|
Number of days of hospitalization
Prazo: The day after surgery (Day -1) and up to 1 month
|
Length of hospital stay in the 2 groups |
The day after surgery (Day -1) and up to 1 month
|
|
VAS values and mode of hospitalization and importance of the surgical procedure
Prazo: The morning of the surgery (Day 0) upon arrival in the operating room
|
Visual Analogue Scale (VAS) of global anxiety is a anxiety self-assessment scale that allows the patient to self-assess his or her anxiety using a cursor, and the mode of hospitalization (ambulatory or conventional) and the importance of the surgical procedure (minor, intermediate or major) |
The morning of the surgery (Day 0) upon arrival in the operating room
|
|
Doses of hypnotic and morphine drugs
Prazo: During anesthetic induction (Day 0)
|
Doses of hypnotic and morphine drugs administered during anesthetic induction (Day 0) in the 2 groups |
During anesthetic induction (Day 0)
|
|
Value of preoperative VAS and adverse events
Prazo: The morning of the surgery (Day 0) upon arrival in the operating room
|
Visual Analogue Scale (VAS) of global anxiety is a anxiety self-assessment scale that allows the patient to self-assess his or her anxiety using a cursor and adverse event variables: pain, agitation, postoperative nausea and vomiting (PONV), ... |
The morning of the surgery (Day 0) upon arrival in the operating room
|
|
Number of Self-questionnaire completed
Prazo: From the day of the anesthesia consultation until the end of the study
|
Self-questionnaire completion rates for each of the 2 pre- and postoperative periods |
From the day of the anesthesia consultation until the end of the study
|
|
Evaluation of the Vecu of General Anesthesia questionnaire (EVAN-G)
Prazo: Two day after surgery (Day 2)
|
The EVAN-G questionnaire includes 26 questions whose results are grouped together to define 6 dimensions: Attention Focus, Information, Privacy, Pain, Discomfort and Wait Times. From these scores, an overall satisfaction score is calculated. The total score of the six dimensions reduced to 100. |
Two day after surgery (Day 2)
|
|
Visual Analogue Scale (VAS) of pain
Prazo: At 1, 2 and 3 month after surgery
|
Visual Analogue Scale (VAS) of pain is a pain self-assessment scale that allows the patient to self-assess his or her pain using a cursor |
At 1, 2 and 3 month after surgery
|
|
Quality of Recovery (QoR)
Prazo: The day after surgery (Day 1)
|
The QoR-15 questionnaire assesses five dimensions of recovery : physical comfort; emotional state; physical independence; physiological support; and pain. Each item was rated on a ten-point Likert scale: none of the time, some of the time, usually, most of the time, and all the time. The total score of 15 ranges from 0 (poorest quality of recovery) to 150 (best quality of recovery). |
The day after surgery (Day 1)
|
|
Insomnia Severity Index Scale (ISI)
Prazo: The day after surgery (Day 1)
|
The Insomnia Severity Index (ISI) includes 7 questions which assesses the nature of the insomnia, the person's satisfaction with sleep, daily functioning and anxiety about sleep problems. Add scores for all seven items, sum from 0-7 = No clinically significant insomnia to 22-28 = Clinical insomnia (severe). |
The day after surgery (Day 1)
|
|
VAS of on satisfaction with overall management and anesthesia
Prazo: The day after surgery (Day 1)
|
Visual Analogue Scale (VAS) of on satisfaction with overall management and anesthesia is a satisfaction self-assessment scale that allows the patient to self-assess his or her satisfaction using a cursor. The scale ranges from 0 (not at all satisfied) to 100 (completely satisfied) |
The day after surgery (Day 1)
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Investigador principal: Régis FUZIER, MD, Institut Universitaire du Cancer Toulouse - Oncopole
- Investigador principal: Lauriane Bordevane, MD, Gustave Roussy, Cancer Campus, Grand Paris
- Cadeira de estudo: Jibba AMRAOUI, MD, Institut régional du cancer de Montpellier
Publicações e links úteis
Publicações Gerais
- Kindler CH, Harms C, Amsler F, Ihde-Scholl T, Scheidegger D. The visual analog scale allows effective measurement of preoperative anxiety and detection of patients' anesthetic concerns. Anesth Analg. 2000 Mar;90(3):706-12. doi: 10.1097/00000539-200003000-00036.
- Caumo W, Schmidt AP, Schneider CN, Bergmann J, Iwamoto CW, Bandeira D, Ferreira MB. Risk factors for preoperative anxiety in adults. Acta Anaesthesiol Scand. 2001 Mar;45(3):298-307. doi: 10.1034/j.1399-6576.2001.045003298.x.
- Maurice-Szamburski A, Auquier P, Viarre-Oreal V, Cuvillon P, Carles M, Ripart J, Honore S, Triglia T, Loundou A, Leone M, Bruder N; PremedX Study Investigators. Effect of sedative premedication on patient experience after general anesthesia: a randomized clinical trial. JAMA. 2015 Mar 3;313(9):916-25. doi: 10.1001/jama.2015.1108.
- Pekcan M, Celebioglu B, Demir B, Saricaoglu F, Hascelik G, Yukselen MA, Basgul E, Aypar U. The effect of premedication on preoperative anxiety. Middle East J Anaesthesiol. 2005 Jun;18(2):421-33.
- Munoz HR, Dagnino JA, Rufs JA, Bugedo GJ. Benzodiazepine premedication causes hypoxemia during spinal anesthesia in geriatric patients. Reg Anesth. 1992 May-Jun;17(3):139-42.
- Agelink MW, Majewski TB, Andrich J, Mueck-Weymann M. Short-term effects of intravenous benzodiazepines on autonomic neurocardiac regulation in humans: a comparison between midazolam, diazepam, and lorazepam. Crit Care Med. 2002 May;30(5):997-1006. doi: 10.1097/00003246-200205000-00008.
- Lehrer PM, Gevirtz R. Heart rate variability biofeedback: how and why does it work? Front Psychol. 2014 Jul 21;5:756. doi: 10.3389/fpsyg.2014.00756. eCollection 2014.
- Jiang H, White MP, Greicius MD, Waelde LC, Spiegel D. Brain Activity and Functional Connectivity Associated with Hypnosis. Cereb Cortex. 2017 Aug 1;27(8):4083-4093. doi: 10.1093/cercor/bhw220.
- Shevde K, Panagopoulos G. A survey of 800 patients' knowledge, attitudes, and concerns regarding anesthesia. Anesth Analg. 1991 Aug;73(2):190-8. doi: 10.1213/00000539-199108000-00013.
- Miller SM. Coping with impending stress: psychophysiological and cognitive correlates of choice. Psychophysiology. 1979 Nov;16(6):572-81. doi: 10.1111/j.1469-8986.1979.tb01523.x. No abstract available.
- Miller SM, Mangan CE. Interacting effects of information and coping style in adapting to gynecologic stress: should the doctor tell all? J Pers Soc Psychol. 1983 Jul;45(1):223-36. doi: 10.1037//0022-3514.45.1.223.
- Jamison RN, Taft K, O'Hara JP, Ferrante FM. Psychosocial and pharmacologic predictors of satisfaction with intravenous patient-controlled analgesia. Anesth Analg. 1993 Jul;77(1):121-5.
- Kulik JA, Mahler HI, Moore PJ. Social comparison and affiliation under threat: effects on recovery from major surgery. J Pers Soc Psychol. 1996 Nov;71(5):967-79. doi: 10.1037//0022-3514.71.5.967.
- Amraoui J, Pouliquen C, Fraisse J, Dubourdieu J, Rey Dit Guzer S, Leclerc G, de Forges H, Jarlier M, Gutowski M, Bleuse JP, Janiszewski C, Diaz J, Cuvillon P. Effects of a Hypnosis Session Before General Anesthesia on Postoperative Outcomes in Patients Who Underwent Minor Breast Cancer Surgery: The HYPNOSEIN Randomized Clinical Trial. JAMA Netw Open. 2018 Aug 3;1(4):e181164. doi: 10.1001/jamanetworkopen.2018.1164.
- McCraty R, Atkinson M, Tiller WA, Rein G, Watkins AD. The effects of emotions on short-term power spectrum analysis of heart rate variability. Am J Cardiol. 1995 Nov 15;76(14):1089-93. doi: 10.1016/s0002-9149(99)80309-9.
- Amraoui J, Bordenave L, Leclerc G, Salvignol G, Jarlier M, Fiess C, Philibert L, Fuzier R, Touraine C. Benefits of cardiac coherence combined with medical hypnosis on preoperative anxiety before cancer surgery: the COHEC II study trial protocol. BMJ Open. 2023 Dec 12;13(12):e072215. doi: 10.1136/bmjopen-2023-072215.
Links úteis
- <p>2. Amouroux R, Rousseau-Salvador C, Annequin D. L'anxiété préopératoire: manifestations cliniques, évaluation et prévention. Ann Méd-PsycholRevPsychiatr; 2010; 168:588-92</p>
- <p>Servant D, Lebeau JC, Mouster Y et al. Cardiac variability, a good indicator of emotion regulation. Journal of cognitive behavioral therapy 2008; 18: 45-8.</p>
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Início do estudo
Conclusão Primária (Real)
Conclusão Primária
Conclusão do estudo (Real)
Conclusão do estudo
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Primeira postagem
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última Atualização Postada
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
Outros números de identificação do estudo
- PROICM 2021-09 COH
- 2021-A01524-37 (Identificador de registro: ID RCB)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
All data will be available after publication of the results in peer-reviewed revues, and in national and international meetings. It includes all de-identified participants' data, the study protocol, the statistical analysis plan and the clinical study report. The corresponding author will provide data and datasets generated and/or analyzed during the study upon reasonable request.
Prazo de Compartilhamento de IPD
Access to study data upon written detailed request sent to ICM, from 6 months until 5 years after publication of summary data.
Critérios de acesso de compartilhamento IPD
The data shared will be limit to that required for independent mandated verification of the published results, the applicant will need authorization from ICM for personal access, and data will only be transferred after signing of a data access agreement.
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- CSR
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .